Analysis of the Western European Clinical Laboratories Market

News provided by

Jan 06, 2016, 02:35 ET

NEW YORK, Jan. 6, 2016 /PRNewswire/ -- Analysis of the Western European Clinical Laboratories Market : Public Hospital Service Outsourcing to Drive the Growth of Independent Reference Labs

Laboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, company profiling, and key trends for the clinical laboratory market and its segments, namely Independent reference laboratories, hospital laboratories, and physician office laboratories. Regional analysis includes Western European countries, such as the United Kingdom, Germany, France, Italy, Spain, BENELUX, and Scandinavia. The period covered in the study is 2012–2020, with 2015 as base year.

Key Findings

The Western European clinical lab market will continue to grow from $ Billion in 2015 to $ Billion in 2020, at a compound annual growth rate (CAGR) of % from 2015 to 2020.

- The hospital labs segment is the largest in terms of volume and revenues. However, competition is expected to arise from the independent clinical labs to compete with sub-contracting/outsourcing contracts, from both public and private hospitals.

- The outsourcing of clinical testing services by public hospitals to the independent reference labs, due to budgetary constraints, is expected to be a key driver of growth towards the independent reference labs section. Constraints also remain on outsourcing; for example, the limit on test volume outsourcing is set to % in France.

- Physician office labs (POL) is the smallest segment and is expected to have low growth, mainly due to reduction and low reimbursements. In Germany, POL tests are restricted by constraints in the Federal Laboratory Reform, where self-referral or in-office performance of lab tests is recognised under a point-based schedule established by the Gesetzliche Krankenversicherung (GKV), the government's health insurance system.

- Compulsory accreditation of clinical labs and relaxation in the number of biologists per clinical site are the main trends with regard to lab regulations.

Notably, the leading companies in the market are Labco, Sonic Healthcare, Unilabs, Synlab, and LADR International. Consolidation among large participants is a common trend witnessed in this market. Examples include Cinven acquiring Labco and Synlab. The key differentiating competitive factors in the Western European clinical lab services are the prices of tests and the quality of services.

- Key growth areas in the clinical lab services include diabetes, cardiovascular testing, and genetic tests.

- In the regional perspective, Germany and France are the most attractive sectors in the private independent labs segment. A number of privatisation activities is expected in the clinical lab services: o Germany: Increasing consolidation activity by private companies o France: Centralisation and concentration of analyses in an accredited lab o England: Increasing privatisation activities through private-public partnerships

Read the full report: http://www.reportlinker.com/p03548143-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com